Lapix Therapeutics Inc. research brief

CIK 1947620 Copy CIK

Generated Nov. 4, 2026, 9:45 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: Cambridge MA. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Aug. 5, 2025 · D · 0001947620-25-000003 · Source evidence

  Reported offering amount: 5000000 USD. Reported amount sold: 2200000 USD.

• Feb. 10, 2025 · D/A · 0001947620-25-000001 · Source evidence

  Reported offering amount: 6000000 USD. Reported amount sold: 5520946 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Lapix Therapeutics Inc. research brief,” CIK 1947620, retrieved Nov. 4, 2026, 9:45 a.m.. Cite the specific accessions used. No amounts have been summed.